准备和初步结构-活动关系研究 施瓦兹尼辛A类同类作为血管松剂
Fong-Kai Lee1, Nathaniel Jia-Yoong Chan2, Premanand Krishnan3
1Faculty of Pharmacy and Biomedical Sciences, MAHSA University, 42610 Jenjarom, Selangor, Malaysia.
来自Ficus schwarzii的 Schwarzinicines A-D显示了血管松活性. 这项研究合成了57种施瓦辛辛A的类似物,确定了关键的结构特征,并发现了四种具有显著增强潜在药物开发功能的类似物.
科学领域:
- 自然产品化学 自然产品化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- Schwarzinicines A-D,Ficus schwarzii中的类化合物,具有显著的血管松性质.
- 之前的施瓦辛辛素A和B的合成使得进一步的生物学研究成为可能.
- 了解结构-活性关系对于开发强效治疗剂至关重要.
研究的目的:
- 为了探索 schwarzinicine A. 周围的化学空间.
- 为了确定血管松活性必不可少的结构元素.
- 为了发现具有更强效的新型类似物.
主要方法:
- 基于施瓦尔津辛A支架的57种类型的合成.
- 在实验室中测试血管松剂活性,使用老鼠隔离的大动脉.
- 同类疗效 (Emax) 和强度 (EC50) 的比较.
- 用分子动力学模拟来研究与TRPC6.6的结合相互作用.
主要成果:
- 确定了对血管松活性至关重要的结构特征.
- 发现了四种类似物,与施华津辛A相比,其强度增加了多达40.2倍.
- 模拟器44显示了与TRPC6蛋白中的关键残留物的潜在相互作用.
结论:
- 对于施华津A类型的已确立的结构-活性关系.
- 确定了用于进一步药物开发的高强度类似物.
- 提供了优化施华津辛的基础,为发现优质血管松剂提供了一个支架.
更多相关视频
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
07:32Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine
Published on: October 7, 2014
相关概念视频
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Antihypertensive Drugs: Vasodilators
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
